Apollo Hospitals Share Price Target 2026: Analyst Consensus, Bull Case & Bear Case

Updated: 13 Apr 2026 • 11:59 am

Posted by:

Apollo Hospitals Share Price Target 2026: Analyst Consensus, Bull Case & Bear Case

Apollo Hospitals (Healthcare Ecosystem) is trading at Rs 5,800 as of April 2026, with a 52-week range from Rs 5,200 to Rs 7,650 and a 1-year return of -24%. The analyst consensus 12-month Apollo Hospitals share price target stands at Rs 6,800-7,500 — implying meaningful potential movement from current levels.

Whether you are a long-term holder reassessing your position or a new investor evaluating entry levels, understanding where analysts see Apollo Hospitals heading over the next 12-24 months requires looking beyond the CMP. This article covers the key catalysts and risks, technical levels, institutional positioning, and a structured breakdown of the short-term, 12-month, and long-term Apollo Hospitals share price targets.

Click Here — Get Free Investment Predictions on Univest.

Table of Contents

Apollo Hospitals Key Data — CMP, Valuation, Fundamentals

Parameter	Value
CMP (April 2026)	Rs 5,800
52-Week High	Rs 7,650
52-Week Low	Rs 5,200
1-Year Return	-24%
Trailing P/E	72x
Price-to-Book	15x
Market Cap	Rs 83,000 Cr
Sector	Healthcare Ecosystem
Promoter Holding	29.3%
FII Holding	30.6%
DII Holding	22.4%

Track live Apollo Hospitals fundamentals and analyst ratings on the Univest Screener.

Apollo Hospitals Share Price Targets — Short-Term, 12-Month & Long-Term

Access premium analyst research on Univest.

Scenario	Target	Basis
Short-Term (3-6M)	Rs 6,800	Technical support; near-term catalyst
12-Month Consensus	Rs 6,800-7,500	Analyst consensus based on current fundamentals
Bull Case (FY28)	Rs 9,000	Full execution of growth catalysts below
Bear Case	Rs 4,500	Materialisation of key risks below

Bull Case — What Has to Go Right for Apollo Hospitals

1. Apollo 24|7 digital platform turning EBITDA positive in FY27 removes the loss-drag on consolidated profitability

Apollo 24|7 digital platform turning EBITDA positive in FY27 removes the loss-drag on consolidated profitability

2. International medical tourism recovery

Apollo treats 100,000+ international patients annually

3. Pharmacy network (5,000+ outlets) generating Rs 2,000+ crore EBITDA with high growth

Pharmacy network (5,000+ outlets) generating Rs 2,000+ crore EBITDA with high growth

4. ARPOB increasing in high-value specialties (oncology, transplants, cardiac) as clinical outcomes differentiate Apollo

ARPOB increasing in high-value specialties (oncology, transplants, cardiac) as clinical outcomes differentiate Apollo

5. India’s healthcare spending per capita growing from $80 to $200+ over the next decade

structural demand tailwind

Bear Case — Key Risks to the Apollo Hospitals Share Price Target

Risk 1: Apollo 24|7 remaining loss-making beyond FY28

digital healthcare is structurally low-margin

Risk 2: Competition from Max Healthcare, Manipal, and Aster DM intensifying in South India and NCR

Competition from Max Healthcare, Manipal, and Aster DM intensifying in South India and NCR

Institutional Sentiment and Technical Analysis

Apollo Hospitals has 30.6% FII holding and 22.4% DII holding. High FII ownership of 30.6% means the stock is sensitive to global risk-off events — FII selling can be disproportionate to any specific negative news.

Technically, Apollo Hospitals is trading at Rs 5,800 against a 52-week range of Rs 5,200 to Rs 7,650. The -24% 1-year return positions the stock in negative territory — creating both risk of further downside and opportunity for mean reversion. The 12-month analyst target of Rs 6,800-7,500 implies the stock is expected to recover meaningfully from current depressed levels.

Download the Univest iOS App or Univest Android App for real-time research and analyst updates.

Conclusion — Our View on ${name} Share Price Target

Apollo Hospitals at Rs 5,800 is the premium healthcare compounder. The current 24% correction from the peak is primarily valuation normalisation. At 72x trailing P/E, the stock remains expensive but the quality of the business — brand, clinical outcomes, digital platform, pharmacy — justifies a premium. 12-month target of Rs 6,800-7,500 implies 17-29% upside. Ideal for long-term healthcare investors.

Subscribe to Univest Pro for SEBI-registered analyst recommendations — entry, target, stop-loss.

Frequently Asked Questions

Q1. What is Apollo Hospitals share price target 2026?

Apollo Hospitals share price target for 2026 is Rs 6,800-7,500 based on analyst consensus. The bull case target is Rs 9,000 and the bear case is Rs 4,500. These are analyst estimates, not guaranteed returns.

Q2. Is Apollo Hospitals a good buy now?

Apollo Hospitals is trading at Rs 5,800 against a 52-week range of Rs 5,200 to Rs 7,650. Analyst consensus target of Rs 6,800-7,500 implies upside from current levels. Consult a SEBI-registered financial advisor before investing.

Q3. What is Apollo Hospitals’s current valuation?

Apollo Hospitals trades at a trailing P/E of 72x and price-to-book of 15x with a market capitalisation of Rs 83,000 Cr. The stock’s valuation relative to earnings growth determines the appropriate entry point.

Q4. What are the key risks for Apollo Hospitals?

Key risks for Apollo Hospitals include the factors outlined in the Bear Case section of this article. Apollo 24|7 remaining loss-making beyond FY28 is the primary near-term risk to watch.

Q5. Where can I track Apollo Hospitals share price live?

Track Apollo Hospitals share price live, quarterly results, FII/DII activity, and analyst ratings on the Univest Screener at univest.in/screeners. Download the Univest iOS or Android App for daily research.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All analyst targets are estimates and may change. Verify all numbers before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

For more stock research, visit Univest Blogs.